Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities

v3.22.1
Accrued Expenses and Other Current Liabilities
12 Months Ended
Dec. 31, 2021
Accrued Expenses and Other Current Liabilities  
Accrued Expenses and Other Current Liabilities

6. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

December 31, 

    

2021

    

2020

Compensation and benefits

$

2,132

$

2,919

Commercial expenses

107

605

Legal expenses

124

784

Clinical trial expenses

 

550

 

Pharmaceutical development expenses

 

161

 

413

Credit balances to customers

87

Accrued purchases

271

Other accrued expenses and other current liabilities

 

415

 

447

Total accrued expenses and other current liabilities

$

3,847

$

5,168